Amarin defies critics with more positive Vascepa data

Amarin Corp. has released new data from a study showing that its fish oil medication, Vascepa, can significantly reduce the occurrence of several adverse heart events.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news